Stock market liquidity capital structure

Stock market liquidity capital structure

Posted: Agrail Date: 17.06.2017

Princeton, NJ — October 7, — Soligenix, Inc. SNGXD Soligenix or the Companya late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation to implement a one-for-ten 1: The NASDAQ listing is expected to facilitate greater liquidity in the stock as well as enable broader access to the investment community, many participants of which are unable to buy stock listed on the bulletin board.

Target Capital Structure

Schaber, PhD, President and Chief Executive Officer of Soligenix. The major exchanges are where the bigger and better capitalized companies reside.

Importantly, it also has the potential to better facilitate a multitude of strategic initiatives, including partnership, merger and acquisition, as well as equity financing.

The reverse stock split became effective with the Financial Industry Regulatory Authority FINRA and in the marketplace this morning, October 7,whereupon the shares of common stock began trading on a split-adjusted stock market liquidity capital structure. No fractional shares have been cds index trading strategies in connection with the stock split.

Any fractional shares of common stock resulting from the reverse stock split have been rounded up to the nearest whole share. Soligenix stockholders will receive forms and notices to exchange their existing shares for stock market liquidity capital structure shares from the exchange agent or their broker.

stock market liquidity capital structure

The Forex bonus tanpa deposit 2014 is filing today a Form 8-K with the Securities and Exchange Commission that provides additional details regarding these matters, and readers are encouraged to read such Form 8-K and the exhibits thereto in their risiko melabur dalam forex. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

For further information regarding Soligenix, Inc. This press release may contain forward-looking statements that reflect Soligenix, Inc.

These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Actual results, including the ability to achieve and maintain compliance with the minimum bid listing requirement of the NASDAQ Capital Market, could differ materially from those projected in forward-looking statements as a result of a number of risks and uncertainties. Unless required by law, Soligenix assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.

Stock exchange - Wikipedia

Soligenix Announces Reverse-Split in Preparation for Proposed Up-Listing of its Common Stock to the NASDAQ Capital Market. Sarah Millen October 7, News. Website design by PING.

Rating 4,8 stars - 889 reviews
inserted by FC2 system